Linked Life Data

6253403

Source:http://linkedlifedata.com/resource/pubmed/id/6253403

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6253403rdf:typepubmed:Citationlld:pubmed
pubmed-article:6253403lifeskim:mentionsumls-concept:C0014080lld:lifeskim
pubmed-article:6253403lifeskim:mentionsumls-concept:C0003451lld:lifeskim
pubmed-article:6253403lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:6253403lifeskim:mentionsumls-concept:C0021747lld:lifeskim
pubmed-article:6253403lifeskim:mentionsumls-concept:C0032414lld:lifeskim
pubmed-article:6253403lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6253403lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:6253403lifeskim:mentionsumls-concept:C1510811lld:lifeskim
pubmed-article:6253403lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:6253403lifeskim:mentionsumls-concept:C0524527lld:lifeskim
pubmed-article:6253403lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:6253403pubmed:issue3lld:pubmed
pubmed-article:6253403pubmed:dateCreated1981-1-26lld:pubmed
pubmed-article:6253403pubmed:abstractTextTreatment of mice with polyinosinic acid . polycytidylic acid [poly(I) . poly(C)] 6 h before infection and once daily on days 1, 2, 3, 4, 7, and 10 after infection with encephalomyocarditis virus was found to confer no additional protection as compared with a single treatment 6 h before infection. When complexed with a colloid formed between carboxymethylcellulose and polylysine, poly(I) . poly(C) conferred significant additional protection with the multiple treatment regimen compared with a single treatment of 6 h before infection. The additional antiviral activity of multiple treatments could not be entirely attributed to interferon induction by the complexed form of poly(I) . poly(C), because free and complexed poly(I) . poly(C) both caused hyporesponsiveness to interferon induction after multiple treatments. However, mice protected against encephalomyocarditis virus infection by multiple treatments with the colloidal complex form of poly(I) . poly(C) showed a significant increase in resistance to reinfection, and this was attributable to adjuvant effects of the colloidal complex form of poly(I) . poly(C). The contribution of interferon induction and adjuvanticity of the poly(I) . poly(C) formulations varied with the times of treatment relative to infection, the dose of polynucleotide material, and the virus dose.lld:pubmed
pubmed-article:6253403pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:languageenglld:pubmed
pubmed-article:6253403pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:citationSubsetIMlld:pubmed
pubmed-article:6253403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6253403pubmed:statusMEDLINElld:pubmed
pubmed-article:6253403pubmed:monthSeplld:pubmed
pubmed-article:6253403pubmed:issn0019-9567lld:pubmed
pubmed-article:6253403pubmed:authorpubmed-author:StebbingNNlld:pubmed
pubmed-article:6253403pubmed:authorpubmed-author:LindleyI JIJlld:pubmed
pubmed-article:6253403pubmed:authorpubmed-author:DawsonK MKMlld:pubmed
pubmed-article:6253403pubmed:issnTypePrintlld:pubmed
pubmed-article:6253403pubmed:volume29lld:pubmed
pubmed-article:6253403pubmed:ownerNLMlld:pubmed
pubmed-article:6253403pubmed:authorsCompleteYlld:pubmed
pubmed-article:6253403pubmed:pagination960-5lld:pubmed
pubmed-article:6253403pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:6253403pubmed:meshHeadingpubmed-meshheading:6253403-...lld:pubmed
pubmed-article:6253403pubmed:meshHeadingpubmed-meshheading:6253403-...lld:pubmed
pubmed-article:6253403pubmed:meshHeadingpubmed-meshheading:6253403-...lld:pubmed
pubmed-article:6253403pubmed:meshHeadingpubmed-meshheading:6253403-...lld:pubmed
pubmed-article:6253403pubmed:meshHeadingpubmed-meshheading:6253403-...lld:pubmed
pubmed-article:6253403pubmed:meshHeadingpubmed-meshheading:6253403-...lld:pubmed
pubmed-article:6253403pubmed:meshHeadingpubmed-meshheading:6253403-...lld:pubmed
pubmed-article:6253403pubmed:meshHeadingpubmed-meshheading:6253403-...lld:pubmed
pubmed-article:6253403pubmed:meshHeadingpubmed-meshheading:6253403-...lld:pubmed
pubmed-article:6253403pubmed:meshHeadingpubmed-meshheading:6253403-...lld:pubmed
pubmed-article:6253403pubmed:year1980lld:pubmed
pubmed-article:6253403pubmed:articleTitleVariations in the contribution of induced interferon and adjuvanticity to the antiviral effect of different polyinosinic acid . polycytidylic acid formulations in mice infected with encephalomyocarditis virus.lld:pubmed
pubmed-article:6253403pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6253403lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6253403lld:pubmed